Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: Tumor treating fields enhance anti-PD therapy by improving CCL2/8 and CXCL9/CXCL10 expression through inducing immunogenic cell death in NSCLC models

Original Submission
11 Dec 2024 Submitted Original manuscript
18 Dec 2024 Author responded Author comments - Yuanzhen Suo
13 Jan 2025 Reviewed Reviewer Report
23 Jan 2025 Reviewed Reviewer Report
27 Jan 2025 Reviewed Reviewer Report
28 Jan 2025 Reviewed Reviewer Report - Shahram Taeb
13 Feb 2025 Author responded Author comments - Yuanzhen Suo
Resubmission - Version 2
18 Dec 2024 Submitted Manuscript version 2
20 Feb 2025 Reviewed Reviewer Report
21 Feb 2025 Reviewed Reviewer Report - Shahram Taeb
23 Feb 2025 Reviewed Reviewer Report
27 Feb 2025 Author responded Author comments - Yuanzhen Suo
Resubmission - Version 3
27 Feb 2025 Submitted Manuscript version 3
28 Feb 2025 Author responded Author comments - Yuanzhen Suo
Resubmission - Version 4
28 Feb 2025 Submitted Manuscript version 4
Publishing
4 Mar 2025 Editorially accepted
17 Mar 2025 Article published 10.1186/s12885-025-13859-w

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us